Immune Network Research Ltd., Jacobus Pharmaceuticals Co. Inc. deal

The companies signed a letter of intent for IMMFF to grant Jacobus an exclusive license to its data and IP for dapsone to treat Alzheimer's disease (AD) and other indications. IMMFF will receive a roy...